SEC Form 4
CVS HEALTH CORPORATION (CVS) insider trading
In the 12 months to Oct 24, 2026, 2 CVS insiders reported open-market sales of $323.7M across 2 filings; one EVP and president, aetna bought $1.3K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $323.7M
- 2 filings · 2 insiders
- Open-market purchases
- $1.3K
- 1 filing · Steven H. Nelson, EVP and President, Aetna
Who traded CVS, and when
- Purchase
- Sale
CVS daily close from Oct 24, 2025 to Oct 23, 2026, between $70.08 and $110.60, last $93.47. 2 sale and 1 purchase filings by 3 insiders, marked at their filing dates. Larry Robbins, Director: sold $317.5M across 1 filing, first filed May 21, 2026, last May 21, 2026. Tilak Mandadi, EVP, Chief Exp & Tech Officer: sold $6.2M across 1 filing, first filed May 11, 2026, last May 11, 2026. Steven H. Nelson, EVP and President, Aetna: bought $1.3K across 1 filing, first filed Jan 27, 2026, last Jan 27, 2026.
Largest mark · tap a row for others
Larry Robbins · Director
Sale $317,471,136
3,372,000 shares at $94.15 avg
Filed May 21, 2026 · traded May 19
Close on filing date $93.32
Larry Robbins · Director
Director
$317.5M soldTilak Mandadi · EVP, Chief Exp & Tech Officer
EVP, Chief Exp & Tech Officer
$6.2M soldSteven H. Nelson · EVP and President, Aetna
EVP and President, Aetna
$1.3K boughtHas CVS HEALTH CORPORATION's CEO sold stock?
No. J. David Joyner (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
3 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Larry Robbins | Director | $317.5M | — | 1 | — | |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | $6.2M | — | 1 | — | |
| Steven H. Nelson | EVP and President, Aetna | — | $1.3K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Larry Robbins Director | Sale | 3,372,000 | $94.15 | $317.5M | 4,824,799 | |
traded | Tilak Mandadi EVP, Chief Exp & Tech Officer | Sale | 69,551 | $89.58 | $6.2M | 10,133 | |
traded | Steven H. Nelson EVP and President, Aetna | Purchase | 24 | $53.70 | $1.3K | 24 |
GET /stocks/filings/vX/form-4?tickers=CVS&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CVS"
],
"issuer_cik": "0000064803",
"owner_cik": "0001228603",
"accession_number": "0000905148-26-002617",
"form_type": "4",
"filing_date": "2026-05-21",
"period_of_report": "2026-05-19",
"issuer_name": "CVS HEALTH Corp",
"issuer_trading_symbol": "CVS",
"owner_name": "ROBBINS LARRY",
"is_director": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-05-19",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 151,
"transaction_price_per_share": 95.18,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 6213261,
"transaction_value": 14372.18,
"direct_or_indirect": "I",
"nature_of_ownership": "Held by Glenview Investment Funds",
"footnotes": [
{
"id": "F1",
"description": "These shares of the Issuer's common stock (the \"Shares\") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the \"GO Fund\"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the \"Glenview Investment Funds\")."
},
{
"id": "F3",
"description": "The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein."
},
{
"id": "F4",
"description": "The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares."
}
]
},
{
"tickers": [
"CVS"
],
"issuer_cik": "0000064803",
"owner_cik": "0001228603",
"accession_number": "0000905148-26-002617",
"form_type": "4",
"filing_date": "2026-05-21",
"period_of_report": "2026-05-19",
"issuer_name": "CVS HEALTH Corp",
"issuer_trading_symbol": "CVS",
"owner_name": "ROBBINS LARRY",
"is_director": true,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-05-21",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 370462,
"transaction_price_per_share": 93.4482,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 4824799,
"transaction_value": 34619007.0684,
"direct_or_indirect": "I",
"nature_of_ownership": "Held by Glenview Investment Funds",
"footnotes": [
{
"id": "F1",
"description": "These shares of the Issuer's common stock (the \"Shares\") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the \"GO Fund\"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the \"Glenview Investment Funds\")."
},
{
"id": "F9",
"description": "This price reflects the weighted average price for open-market sales of Shares on May 21, 2026 within a $1.00 range. The actual prices for these transactions range from $93.125 to $93.83, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price."
},
{
"id": "F3",
"description": "The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein."
},
{
"id": "F4",
"description": "The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 43 records
- Tax withholding17 records
- Grants and awards24 records
- Other2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CVS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.